| ncRNA name | PKCθ shRNA |
| ncRNA Category | shRNA |
| Disease name | uveal melanoma (UM) |
| Species | Homo sapiens |
| Tissues/Cell_line | UM cell lines Mel202, Omm1.3, C918 and Mel285 |
| Methods | shRNA knockdown, MTS proliferation assay |
| Expression pattern | associated |
| Functional description | Expression of PKCβ, PKCθ or PKCε shRNA significantly decreased viability of Mel202 and Omm1.3 cells (Figure 8D). A reduction in viability was also seen in C918 cells expressing shRNA of PKCβ, PKCε or PKCθ and in Mel285 cells expressing PKCβ or PKCθ. |
| PubMed ID | 22253748 |
| Year | 2012 |
| Title | The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. |
| Drug-related ncRNA | NA |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.